Tuesday, October 27, 2015 3:17:19 PM
Due to the global significance of the problems that Mantra’s technologies are designed to address, the company has become truly international. Subsidiaries have been established in Hong Kong, the UK, and most recently in the German state of Bavaria. These branches have been strategically located in regions that have a demonstrated commitment to addressing the problems of CO2 emissions and sustainable energy, and have expressed the desire to see the successful deployment of Mantra’s technologies. Specifically, the Bavarian brewery Ayinger has agreed to host a second ERC demonstration, for the conversion of CO2 to new products developed by Mantra.
Mantra’s interest in these areas is in part due to the large regional, national and international funding opportunities available specifically for our technologies. The company is dedicated to accessing public funding for its projects whenever possible, and thereby maximizing the value of these projects for its shareholders. Given the innovative nature of our business, the positive reception we have had across regions, and the interest from large industrial partners, we are confident that in the coming year we will successfully obtain a large grant for a pre-commercial technology deployment.
As always, intellectual property remains Mantra’s most critical asset. We are extremely pleased to now have our core ERC patent awarded in four of the six jurisdictions applied, and the core MRFC patent in two of the three. In the interest of expanding this value, and as a result of successful laboratory-scale development, we have over the past year filed an additional five patent applications covering various aspects of our technologies. Our demonstration projects, being the first of their kind, will serve to produce a new generation of intellectual property that will further solidify Mantra’s position as a global leader.
The company has been further validated through the receipt its first recurring revenue, totaling over $330,000 to date, and the establishment and maintenance of close relationships with large multinational companies. As per recent developments, the recurring revenue stream will continue to support our research and development activities as we move our products to the market, and our partners will provide the platform from which this market penetration can be successfully executed.
Looking forward, 2015 is the year in which Mantra will showcase a multitude of first-of-their-kind technology demonstrations. This includes two demonstrations of ERC for the production of a suite of valuable chemicals from CO2, and the demonstration MRFC for large-market applications such as backup and stationary power, industrial equipment, and transportation. Because we have based these demonstration projects on the highest quality research and engineering, we expect their success will lead to the company’s first early license adoptions this year, catapulting Mantra to the next stage of growth.
Recent HWNI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 01:15:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 04:53:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:15:45 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM